01-04-2002
A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by l-dopa
Published in: Journal of Neural Transmission | Issue 4/2002
Login to get access